Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

ClinicalTrials.gov ID: NCT02547935

Public ClinicalTrials.gov record NCT02547935. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory Phase II/III, Randomized, Double-blind, Placebo Controlled, Parallel Design Study to Evaluate the Efficacy, Safety and Pharmacodynamics of Dapagliflozin and Dapagliflozin in Combination With Saxagliptin in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria Treated With ACEi or ARB

Study identification

NCT ID
NCT02547935
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
459 participants

Conditions and interventions

Interventions

  • Dapagliflozin 10 mg Drug
  • Saxagliptin 2.5 mg Drug
  • Matching Placebo for Dapagliflozin 10 mg and Saxagliptin 2.5mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 20, 2015
Primary completion
May 17, 2018
Completion
May 17, 2018
Last update posted
Aug 20, 2019

2015 – 2018

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
37
Facility City State ZIP Site status
Research Site Peoria Arizona 85381
Research Site Chula Vista California 91910
Research Site Concord California 94520
Research Site El Centro California 92243
Research Site La Mesa California 92123
Research Site Long Beach California 90807
Research Site Los Gatos California 95032
Research Site North Hollywood California 91606
Research Site Riverside California 92505
Research Site San Diego California 92111
Research Site San Dimas California 91773
Research Site Hollywood Florida 33024
Research Site Miami Florida 33126
Research Site New Port Richey Florida 34652
Research Site Palm Harbor Florida 34684
Research Site Pompano Beach Florida 33060
Research Site Augusta Georgia 30909
Research Site Meridian Idaho 83642
Research Site Chicago Illinois 60643
Research Site Bangor Maine 04401
Research Site Kansas City Missouri 64111
Research Site Las Vegas Nevada 89148
Research Site Springfield Gardens New York 11413
Research Site The Bronx New York 10459
Research Site Greensboro North Carolina 27408
Research Site Morehead City North Carolina 28557
Research Site Rocky Mount North Carolina 27804
Research Site Philadelphia Pennsylvania 19107
Research Site Greenville South Carolina 29605
Research Site Brownsville Texas 78520
Research Site Cypress Texas 77429
Research Site Houston Texas 77004
Research Site San Antonio Texas 78215
Research Site Sugar Land Texas 77479
Research Site Salt Lake City Utah 84124
Research Site Burke Virginia 22015
Research Site Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02547935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02547935 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →